Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.75
Delayed Data
As of 4:10pm ET
 +0.01 / +0.57%
Today’s Change
1.69
Today|||52-Week Range
7.10
-13.37%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close1.74
Today’s open1.75
Day’s range1.72 - 1.80
Volume264,117
Average volume (3 months)506,142
Market cap$55.2M
Data as of 4:10pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-133.33%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.42

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc+0.03+1.46%
EIGREiger BioPharmaceuti...+0.05+0.58%
NOVNNovan Inc-0.08-2.36%
NBYNovaBay Pharmaceutic...-0.08-2.32%
Data as of 4:00pm ET, 02/21/2018

Financials

Next reporting dateMarch 20, 2018
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$9.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
President &
Chief Financial Officer
Douglas J. Swirsky
Corporate headquarters
Rockville, Maryland

Forecasts